NEVVI Medicare utilization intelligence
or

← back

Provider profile

MANDAL, ROBERT MD

Medical Oncology · NPI 1124012901 · ELGIN, IL

1
Groups
42
Codes · 2024
66,274
Disclosed services

MANDAL, ROBERT is a Medical Oncology in ELGIN, IL, a member of 1 medical group, who billed 42 distinct codes to Medicare Part B in 2024.

Groups: ILLINOIS CANCER SPECIALISTS (ARLINGTON HEIGHTS, IL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

66,274
disclosed services
42
codes billed to Medicare Part B
Prior year · CY2023 54,215 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1756 Injection, iron sucrose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J2469 Injection, palonosetron hcl, 25 mcg
96375 Injection of additional new drug or substance into vein
Q5122 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
96372 Injection of drug or substance under skin or into muscle
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
96413 Administration of chemotherapy into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J3490 Unclassified drugs
85610 Blood test, clotting time
96415 Administration of chemotherapy into vein, each additional hour
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
96361 Infusion into a vein for hydration, each additional hour
J1750 Injection, iron dextran, 50 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96360 Infusion into a vein for hydration, 31-60 minutes
J7030 Infusion, normal saline solution , 1000 cc
96417 Administration of additional new drug or substance into vein, 1 hour or less
80053 Blood test, comprehensive group of blood chemicals
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
83615 Lactate dehydrogenase (enzyme) level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.